- Home
- CCSI vs TNGX Comparison
CCSI vs TNGX Comparison
Compare CCSI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- TNGX
- Stock Information
- Founded
- CCSI 2021
- TNGX 2014
- Country
- CCSI United States
- TNGX United States
- Employees
- CCSI N/A
- TNGX N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- CCSI Technology
- TNGX Health Care
- Exchange
- CCSI Nasdaq
- TNGX Nasdaq
- Market Cap
- CCSI 476.8M
- TNGX 413.6M
- IPO Year
- CCSI N/A
- TNGX N/A
- Fundamental
- Price
- CCSI $25.07
- TNGX $2.85
- Analyst Decision
- CCSI Hold
- TNGX Strong Buy
- Analyst Count
- CCSI 5
- TNGX 8
- Target Price
- CCSI $26.20
- TNGX $13.14
- AVG Volume (30 Days)
- CCSI 96.8K
- TNGX 1.2M
- Earning Date
- CCSI 02-19-2025
- TNGX 11-06-2024
- Dividend Yield
- CCSI N/A
- TNGX N/A
- EPS Growth
- CCSI 16.33
- TNGX N/A
- EPS
- CCSI 4.56
- TNGX N/A
- Revenue
- CCSI $351,153,000.00
- TNGX $43,383,000.00
- Revenue This Year
- CCSI N/A
- TNGX $27.73
- Revenue Next Year
- CCSI N/A
- TNGX N/A
- P/E Ratio
- CCSI $5.50
- TNGX N/A
- Revenue Growth
- CCSI N/A
- TNGX 15.67
- 52 Week Low
- CCSI $11.62
- TNGX $2.59
- 52 Week High
- CCSI $27.79
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- CCSI 58.32
- TNGX 41.79
- Support Level
- CCSI $24.22
- TNGX $2.60
- Resistance Level
- CCSI $25.17
- TNGX $3.65
- Average True Range (ATR)
- CCSI 0.78
- TNGX 0.25
- MACD
- CCSI 0.12
- TNGX 0.01
- Stochastic Oscillator
- CCSI 87.93
- TNGX 24.88
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.